SLNO — SOLENO THERAPEUTICS INC

Ownership history in Squarepoint Ops LLC  ·  13 quarters on record

This page tracks every 13F SEC filing in which Squarepoint Ops LLC reported a position in SOLENO THERAPEUTICS INC (SLNO). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.02% (2025 Q4)
Avg. % of fund
0.0%
First filed
2020 Q1
Last filed
2025 Q4
Quarters held
13
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 468,654 +457,354 +4047.4% 0.02% $21.7M $46.30
2025 Q3 REDUCED 11,300 -57,654 -83.6% 0.00% $764K $67.60
2025 Q3 ADDED 68,954 +56,454 +451.6% 0.00% $4.7M $67.60
2025 Q1 ADDED 12,500 +6,600 +111.9% 0.00% $893K $71.45
9 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    SLNO price (monthly, adj. close)

Other funds also holding SLNO

As of 2025 Q4 — sorted by position size

Ally Bridge Group (NY) LLC 3Y 8.1% GREAT POINT PARTNERS LLC 3Y 7Y 6.0% Buckley Capital Advisors, LLC 4.86% Seven Fleet Capital Management LP 4.58% Commodore Capital LP 3Y 3.7% Artia Global Partners LP 3Y 3.5% Catalio Capital Management, LP 2.95% Vivo Capital, LLC 3Y 7Y 2.68% Brummer Multi-Strategy AB 2.45% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 2.2%
← Back to Squarepoint Ops LLC Holdings